A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human Thrombopoietin

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human Thrombopoietin
Epistemonikos ID: 5f47084ccc4f6b3d6251906b8d5b261f0c2f2a15
First added on: Apr 17, 2025